Exopharm
Manufacturing · 11-50 Employees
View Company Info for Free
Overview
Phone Number
+61 391110026Website
www.exopharm.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About Exopharm
Exopharm Limited (ASX:EX1) is a clinical-stage biopharmaceutical company at the forefront of transformative medicines using exosomes, or extracellular vesicles (EVs), and is pursuing a pipeline-driven platform strategy. Exosomes can be loaded with a variety of active pharmaceutical ingredients (APIs) and can be targeted to selected cell and tissue types (tropism) - improving the safety profile of the APIs and providing better treatments. Exosome delivery of DNA and other gene therapies into the nucleus of the patient's cells can improve treatment of inherited medical conditions. Exosomes are an alternative means of drug delivery inside the body, alongside technologies such as lipid nanoparticles (LNP), cell-penetrating peptides, viral vectors and liposomes. The drug delivery industry is growing at a compound annual growth rate (CAGR) of 5% and is currently valued at about US$175 billion ($233 billion)[1].Explore more
Exopharm Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Exopharm your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Exopharm launches new products
Check out if Exopharm is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Exopharm
Click to see if Exopharm had a recent Job posting/layoffs
Check if Exopharm has recently received funding, and reach out quickly before it becomes old news!
Exopharm, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Exopharm recently announced quarterly report
Funding: Get notified immidiatlly once Exopharm has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Exopharm
Compare insights from companies similar to Exopharm, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Exopharm is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Exopharm is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Exopharm.
Exopharm Tech Stack
A closer look at the technologies used by Exopharm
Exopharm News & Media
Exopharm Limited (ASX:EX1) up 14%, but insiders are still down 49% after purchasing AU$895k of stock last year
Some of the losses seen by insiders who purchased AU$895k worth of Exopharm Limited ( ASX:EX1 ) shares over the past...Exopharm and Astellas Institute for Regenerative Medicine (AIRM) Sign Master Collaborative Services Agreement
Astellas Institute for Regenerative Medicine (AIRM) is a subsidiary of Astellas Pharma Inc., a top 20 global pharmaceutical company Initial services will seek to validate Exopharm's LEAP, LOAD and EVPS technology platforms to manufacture exosomes for Astellas, firstly at Exopharm's...Exopharm Gains US Patent Enabling Commercial Production of Exosome Medicines
US Patent and Trademark Office has granted Exopharm patent US 11202805, for its LEAP™ exosome purification technology. LEAP™ enables large-scale, clinical grade commercial production of exosomes needed to underpin the emerging field of exosome medicines. Exopharm is seeking potential...Exopharm's (ASX:EX1) investors will be pleased with their favorable 85% return over the last year
Passive investing in index funds can generate returns that roughly match the overall market. But if you pick the right...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Exopharm
Sign Up For FreeTo access detailed company insights
Exopharm Limited (ASX:EX1) is a clinical-stage biopharmaceutical company at the forefront of transformative medicines using exosomes, or extracellular vesicles (EVs), and is pursuing a pipeline-driven platform strategy. Exosomes can be loaded with a variety of active pharmaceutical ingredients (APIs) and can be targeted to selected cell and tissue... Read More
